Terms: = Uterine cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Prognosis
4 results:
1. [Preoperative serum creatinine as an independent prognostic biomarker in patients with early-stage cervical adenocarcinoma].
Li N; Chen RZ; Wang FF; Li BH
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(26):1993-1998. PubMed ID: 35817723
[No Abstract] [Full Text] [Related]
2. Survival with Cemiplimab in Recurrent Cervical cancer.
Tewari KS; Monk BJ; Vergote I; Miller A; de Melo AC; Kim HS; Kim YM; Lisyanskaya A; Samouëlian V; Lorusso D; Damian F; Chang CL; Gotovkin EA; Takahashi S; Ramone D; Pikiel J; Maćkowiak-Matejczyk B; Guerra Alía EM; Colombo N; Makarova Y; Rischin D; Lheureux S; Hasegawa K; Fujiwara K; Li J; Jamil S; Jankovic V; Chen CI; Seebach F; Weinreich DM; Yancopoulos GD; Lowy I; Mathias M; Fury MG; Oaknin A;
N Engl J Med; 2022 Feb; 386(6):544-555. PubMed ID: 35139273
[TBL] [Abstract] [Full Text] [Related]
3. Pretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma.
Dobrzycka B; Mackowiak-Matejczyk B; Kinalski M; Terlikowski SJ
Gynecol Oncol; 2013 Mar; 128(3):454-60. PubMed ID: 23206584
[TBL] [Abstract] [Full Text] [Related]
4. [Histology and prognosis of endometrial carcinoma].
Sakamoto A; Hirai Y; Yamauchi K; Kitagawa T; Sugano H; Masubuchi K; Hasumi K
Gan No Rinsho; 1987 Dec; 33(15):1897-900. PubMed ID: 3430742
[TBL] [Abstract] [Full Text] [Related]